STE: STERIS plc (Ireland) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
STERIS signed a $1,600M revolver maturing 2031 and a $500M delayed draw term loan tied to the Xodus Medical acquisition closing.
What this filing says
STERIS entered a new $1,600 million revolving credit facility that replaces its October 2024 credit agreement, maturing November 4, 2031. It also agreed to a delayed draw term loan of up to $500 million that can only be drawn if the Xodus Medical acquisition is completed, which would add debt if the deal closes. Shareholders should note the expanded borrowing capacity and the new debt obligation tied to that acquisition.
Key figures
- Revolving credit facility
- $1,600 million
- Delayed draw term loan
- up to $500 million
- Incremental revolver increase allowed
- up to $800 million
- Revolver maturity
- November 4, 2031
- Term loan principal, years two and three
- 1.25% per quarter
- Term loan principal, years four and five
- 1.875% per quarter
Positive for shareholders
- The new revolver can be increased by up to $800 million, giving the company added borrowing flexibility.
- The facility replaces the existing October 2024 credit agreement with a term running to 2031.
Negative for shareholders
- The delayed draw term loan adds up to $500 million of debt if the Xodus Medical acquisition is completed.
- The loan carries financial covenants limiting leverage and requiring minimum interest coverage, which could restrict the company once funded.
Written by Quantisnow AI from this filing. Not financial advice.
Key terms
- Revolving credit facility:
- A loan arrangement where a company can borrow, repay and borrow again up to a set limit.
- Delayed draw term loan:
- A loan that is committed upfront but only funded later, once specified conditions are met.
- Swingline borrowings:
- Short-term, same-day loans made available under a revolving credit facility for quick cash needs.
- Interest coverage:
- A measure of how easily a company can pay interest on its debt from its operating earnings.
FAQ
Does STERIS plc take on the $500 million loan now?
No. The delayed draw term loan can only be used if the Xodus Medical acquisition is consummated, and its commitments end if that deal is validly terminated or the outside date passes.
When does the new STERIS revolving credit facility mature?
The $1,600 million revolver matures on November 4, 2031, and all unpaid borrowings and interest are due on that date.
Historical context for STE
Across the 19 sessions after earlier STE headlines, the stock closed higher 11 times and lower 8 times, with a median move of 1.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | STE | SPY |
|---|---|---|---|
| Nov 5, 2026 | STERIS Announces Financial Results for Fiscal 2027 Second Quarter | +2.5% | -4.4% |
| Oct 29, 2026 | STERIS Announces Dividend of $0.69 per share | +1.5% | -0.4% |
| Oct 21, 2026 | STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026 | -1.6% | +0.5% |
| Oct 12, 2026 | Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)and 1 other headline that session | +2.1% | -0.1% |
| Sep 2, 2026 | STERIS to Present at the Morgan Stanley Healthcare Conference | +0.3% | +0.4% |
| Aug 6, 2026 | STERIS Announces Financial Results for Fiscal 2027 First Quarter | -0.4% | -0.2% |
Keep researching STE
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- STE insider tradesEvery buy and sale reported by STERIS plc (Ireland) officers, directors and large holders.
- STE earnings historyPast STERIS plc (Ireland) earnings releases, newest first.
- STE financial statementsRevenue, profit, cash flow and balance sheet from STERIS plc (Ireland)'s SEC filings.
- STE dividend historyDividends STERIS plc (Ireland) has declared, with ex-dates and payment dates.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
Follow STE and get a push notification the moment its next story breaks.